INJECTABLE PHARMACEUTICAL COMPOSITION FOR PREVENTING, STABILISING AND/OR INHIBITING PATHOLOGICAL NEOVASCULARIZATION-RELATED CONDITIONS
- Application ID: EP11741232
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Icosa is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 183 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.